Bluebird Bio (BLUE) Stock Statistics & Valuation Metrics

Bluebird Bio has a market cap or net worth of $48.67M. The enterprise value is $85.38M.

Bluebird Bio has 55,331,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bluebird Bio’s return on equity (ROE) is 7.63 and return on invested capital (ROIC) is -82.57%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Bluebird Bio had revenue of 83.81M and earned -240.72M in profits. Earnings per share was -24.84.

In the last 12 months, operating cash flow was -228.79M and capital expenditures -1.68M, giving a free cash flow of -230.47M billion.

Bluebird Bio pays an annual dividend of $177.66, resulting in a dividend yield of ―

Bluebird Bio upcoming earnings date is ―, ―.

Bluebird Bio as a current ratio of 0.48, with Debt / Equity ratio of -199.53%

In the past 12 months, Bluebird Bio has paid 70.00K in taxes.

Bluebird Bio EV to EBITDA ratio is -2.40, with an EV/FCF ratio of -1.43.

Bluebird Bio has $78.74M in cash and marketable securities with $115.46M in debt, giving a net cash position of $36.71M billion.

Gross margin is 27.12%, with operating margin of -322.72%, and net profit margin of -287.23%.

The average price target for Bluebird Bio is $8.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy